Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 5.5
(-0.9%)
CNY 5.5
(-0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 70.69 Million | 29.32 Million | 11.32 Million | -16.74 Million | 45.05 Million | 157.65 Million |
| Net Income | 5.16 Million | -197.95 Million | 10.57 Million | 19.98 Million | -29.95 Million | 21.01 Million |
| Depreciation & Amortization | 77.42 Million | 50.24 Million | 44.65 Million | 50.11 Million | 62.26 Million | 55.93 Million |
| Deferred income taxes | 5.01 Million | -28.39 Million | 4.2 Million | -5.29 Million | 2.61 Million | -957.4 Thousand |
| Stock-based compensation | 17.53 Million | - | - | - | - | - |
| Change in working capital | -68.03 Million | 83.11 Million | -48.2 Million | -122.8 Million | -28.06 Million | 62.97 Million |
| Other non-cash items | 37.99 Million | 93.91 Million | 4.3 Million | 35.95 Million | 40.82 Million | 17.73 Million |
| Investing Cash Flow | -59.47 Million | 13.38 Million | 90.91 Million | -266.48 Million | -48.42 Million | 175.02 Million |
| Investments in PPE | -137.55 Million | -45.1 Million | -219.97 Million | -299.56 Million | -130.98 Million | -291.68 Million |
| Acquisitions | -1.16 Million | 37.74 Million | 333.48 Million | 310.23 Million | -32.13 Million | -271.48 Million |
| Investment purchases | - | - | -360 Million | -354.1 Million | -250.5 Million | -1.56 Billion |
| Sales/Maturities of investments | - | - | 337.26 Million | 376.51 Million | 358.12 Million | 2.3 Billion |
| Other Investing Activities | 73.71 Million | 20.74 Million | 137.99 Thousand | -299.56 Million | 7.07 Million | 165.4 Thousand |
| Financing Cash Flow | -131.78 Million | -36.69 Million | -109.6 Million | 372.37 Million | -64.13 Million | -372.62 Million |
| Debt repayment | -107.74 Million | -255.77 Million | -436.88 Million | -388.26 Million | -244.5 Million | -192.7 Million |
| Dividends payments | -24.34 Million | -26.51 Million | -40.67 Million | -22.57 Million | -67.5 Million | -9.67 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 300 Thousand | 245.59 Million | 367.95 Million | 783.21 Million | 259.15 Million | -170.25 Million |
| Accounts receivables | 2.71 Million | 23.01 Million | -49.59 Million | -76.8 Million | 17.12 Million | 13.32 Million |
| Accounts payables | -8.16 Million | 54.77 Million | -13.38 Million | -849.29 Thousand | -2.73 Million | 47.93 Million |
| Inventory | -67.6 Million | 33.72 Million | 10.57 Million | -39.85 Million | -45.07 Million | 2.66 Million |
| Other working capital | -3.14 Million | -28.39 Million | 4.2 Million | -5.29 Million | 2.61 Million | 60.3 Million |
| Cash at beginning of period | 255.21 Million | 249.07 Million | 256.33 Million | 164.94 Million | 236.16 Million | 124.1 Million |
| Cash at end of period | 134.64 Million | 255.21 Million | 249.07 Million | 256.33 Million | 164.94 Million | 84.16 Million |
| Capital Expenditure | -137.55 Million | -45.1 Million | -219.97 Million | -299.56 Million | -130.98 Million | -291.68 Million |
| Effect of forex changes on cash | -543.89 | 129.64 Thousand | 111.46 Thousand | 2.24 Million | -3.73 Million | - |
| Net cash flow / Change in cash | -120.57 Million | 6.14 Million | -7.25 Million | 91.39 Million | -71.22 Million | -39.93 Million |
| Free Cash Flow | -66.86 Million | -15.77 Million | -208.64 Million | -316.31 Million | -85.92 Million | -134.02 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.86 Million | -54.35 Million | -46.5 Million | 5.16 Million | 31.98 Million | -36.76 Million |
| Depreciation & Amortization | - | 21.48 Million | 21.48 Million | 77.42 Million | 77.42 Million | -34.19 Million |
| Deferred income taxes | - | - | - | 5.01 Million | - | - |
| Stock-based compensation | - | 11.73 Million | - | 17.53 Million | 17.53 Million | - |
| Change in working capital | - | 51.35 Million | - | -68.03 Million | -64.89 Million | 5.77 Million |
| Other non-cash items | 28.67 Million | 105.81 Million | 15.01 Million | 37.99 Million | 44.1 Million | 51.27 Million |
| Investing Cash Flow | -14.69 Million | -26.63 Million | -22.23 Million | -59.47 Million | -21.16 Million | -23.2 Million |
| Investments in PPE | -21.01 Million | -25.22 Million | -22.23 Million | -137.55 Million | -95.67 Million | -23.22 Million |
| Acquisitions | 6 Million | -1.21 Million | - | -1.16 Million | -1.16 Million | 197 Thousand |
| Investment purchases | - | -200 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 316.94 Thousand | -158 Thousand | - | 73.71 Million | 75.66 Million | -180 Thousand |
| Financing Cash Flow | 30.85 Million | -16.89 Million | 23.61 Million | -131.78 Million | -22.85 Million | -29.82 Million |
| Debt repayment | -20.23 Million | -11.84 Million | -28.5 Million | -107.74 Million | -22.79 Million | -34.59 Million |
| Dividends payments | -5.31 Million | -5.04 Million | -4.88 Million | -24.34 Million | -6.85 Million | -5.41 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.93 Million | -5.04 Million | -4.88 Million | 300 Thousand | -38.79 Million | 10.18 Million |
| Accounts receivables | - | 60.14 Million | - | 2.71 Million | 2.71 Million | -71.89 Million |
| Accounts payables | - | - | - | -8.16 Million | - | - |
| Inventory | - | -8.78 Million | - | -67.6 Million | -67.6 Million | 77.66 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 100.72 Million | 114.28 Million | 144.39 Million | 255.21 Million | 93.31 Million | 171.58 Million |
| Cash at end of period | 123.62 Million | 100.72 Million | 114.28 Million | 134.64 Million | 134.64 Million | 93.31 Million |
| Capital Expenditure | -21.01 Million | -25.22 Million | -22.23 Million | -137.55 Million | -95.67 Million | -23.22 Million |
| Effect of forex changes on cash | - | - | - | -543.89 | -543.00 | -11.32 Million |
| Net cash flow / Change in cash | 22.89 Million | -13.56 Million | -30.1 Million | -120.57 Million | 41.32 Million | -78.26 Million |
| Free Cash Flow | -14.2 Million | 4.74 Million | -53.72 Million | -66.86 Million | -7.04 Million | -37.13 Million |
0Q77
AIQUY
HBIA
8930
3184
3DP